A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma ...

Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster ...

Lilly will provide the funding and expertise to advance Laekna’s LAE102, a first-in-class monoclonal antibody targeting the ...

The agreement will give Kuro enough capital to support the development and launch of its menin inhibitor ziftomenib.

Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.